Valuation: INVO Fertility, Inc.

Market Cap 2.86M 2.6M 2.41M 2.17M 4.09M 268M 4.25M 28.94M 11.45M 144M 10.74M 10.51M 457M P/E 2026 *
-0.03x
P/E 2027 * -
Enterprise Value 2.86M 2.6M 2.41M 2.17M 4.09M 268M 4.25M 28.94M 11.45M 144M 10.74M 10.51M 457M EV / Sales 2026 *
0.27x
EV / Sales 2027 * 0.17x
Free-Float
99.52%
Yield 2026 *
-
Yield 2027 * -
1 day-9.17%
1 week-7.23%
Current month+14.14%
1 month-2.26%
3 months-43.91%
6 months-65.83%
Current year-85.52%
1 week 2.14
Extreme 2.1416
2.78
1 month 1.59
Extreme 1.59
2.78
Current year 1.59
Extreme 1.59
91.6
1 year 1.59
Extreme 1.59
91.6
3 years 1.59
Extreme 1.59
7,141.83
5 years 1.59
Extreme 1.59
7,141.83
10 years 1.59
Extreme 1.59
7,141.83
Date Insider Type Main position Quantity % Market Cap. Importance
30/12/25 Other

Chief Financial Officer

4,399 0.2326%
03/12/25 Sell

Director

7 0.0004%
26/08/25 Other

Director

45,000 4.8477%
Change 5-day change 1-year change 3-year change Capi.($)
-9.17%-7.23%-97.18% - 2.86M
-2.55%-5.25%-19.82%+4.44% 186B
-0.54%-0.46%+6.73%+36.65% 126B
+2.19%-2.51%-12.34%+8.91% 118B
-3.09%-6.19%-43.93%+0.52% 93.33B
-1.79%+1.39%-3.14%+78.03% 68.11B
-0.49%+0.08%+11.59%-8.36% 58.96B
-1.49%-2.32%+0.04%+47.92% 55.2B
-0.45%+0.41%-3.74%+42.17% 48.58B
-0.55%+0.95%+0.16%-0.74% 35.56B
Average -1.79%+2.07%-16.16%+23.28% 79B
Weighted average by Cap. -1.07%-0.94%-10.26%+20.29%

Financials

2026 *2027 *
Net sales 10.42M 9.48M 8.76M 7.89M 14.9M 974M 15.46M 105M 41.66M 525M 39.09M 38.26M 1.66B 16.46M 14.97M 13.85M 12.46M 23.54M 1.54B 24.42M 166M 65.81M 830M 61.75M 60.45M 2.63B
Net income -5.44M -4.95M -4.58M -4.12M -7.78M -509M -8.08M -55.01M -21.76M -274M -20.42M -19.99M -868M -3.03M -2.75M -2.55M -2.29M -4.33M -283M -4.49M -30.59M -12.1M -153M -11.35M -11.11M -483M
Net Debt - -
Projected Income Statement - Annual - INVO Fertility, Inc.
Logo INVO Fertility, Inc.
INVO Fertility Inc. is a healthcare services fertility company, which is engaged in expanding access to assisted reproductive technology (ART) care to patients in need. The Company’s principal commercial strategy is focused on building, acquiring, and operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, profitable in vitro fertilization (IVF) clinics. The Company has four operational fertility clinics in the United States. The Company is also engaged in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more connected, intimate, and affordable experience in comparison to other ART treatments.
Employees
-
Date Price Change Volume
17/11/26 $2.180 -9.17% 46,924
16/11/26 $2.400 -7.69% 94,833
13/11/26 $2.600 -3.17% 26,284
12/11/26 $2.685 -0.19% 30,827
11/11/26 $2.690 +7.60% 22,941
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.400USD
Average target price
80.00USD
Spread / Average Target
+3,233.33%